Regadenoson 36000-0364-01

Package NDC

36000-0364-01

Manufacturer: Baxter Healthcare Corporation
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: May 23, 2023
Listing Expires: December 31, 2026
Application: ANDA217455

Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Regadenoson	.08 mg/mL

Drug Class

Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]

Selected Package

36000-0364-01Selected

1 SYRINGE, PLASTIC in 1 CARTON (36000-364-01) / 5 mL in 1 SYRINGE, PLASTIC